Review



cyt c  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc cyt c
    Cyt C, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2961 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm41690088-71-31-41?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 2961 article reviews
    cyt c - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    Thermo Fisher cytochrome c cyt c
    Cytochrome C Cyt C, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm41894877-91-4-18?v=Thermo+Fisher
    Average 96 stars, based on 1 article reviews
    cytochrome c cyt c - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    86
    Affinity Biosciences cytochrome c cyt c
    Cytochrome C Cyt C, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pmc12914111-39-0-70?v=Affinity+Biosciences
    Average 86 stars, based on 1 article reviews
    cytochrome c cyt c - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Galectin Therapeutics apo cyt c
    Apo Cyt C, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm42046264-195-86-18?v=Galectin+Therapeutics
    Average 86 stars, based on 1 article reviews
    apo cyt c - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Oroboros Instruments cyt c
    PolG Mut mitochondria possess selective impairments to <t>NAD-linked</t> <t>Respiration</t> (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.
    Cyt C, supplied by Oroboros Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pmc13019506-287-18-13?v=Oroboros+Instruments
    Average 86 stars, based on 1 article reviews
    cyt c - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Wanleibio cyt c
    PolG Mut mitochondria possess selective impairments to <t>NAD-linked</t> <t>Respiration</t> (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.
    Cyt C, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm41833110-69-48-51?v=Wanleibio
    Average 86 stars, based on 1 article reviews
    cyt c - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    Thermo Fisher antibody against cytochrome c cyt c
    PolG Mut mitochondria possess selective impairments to <t>NAD-linked</t> <t>Respiration</t> (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.
    Antibody Against Cytochrome C Cyt C, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm41812974-118-11-22?v=Thermo+Fisher
    Average 96 stars, based on 1 article reviews
    antibody against cytochrome c cyt c - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    86
    Nanjing Jiancheng Bioengineering Research Institute Co Ltd cyt c
    ACO2 overexpression protected against LIRI in mice. (A) Schematic of AAV9-mediated ACO2-OE in I/R mice. (B–C) ACO2 expression levels assessed by RT-qPCR and western blot. (D) Blood gas parameters (PaO 2 and PaCO 2 ) following I/R injury. (E) Representative H&E-stained lung sections (scale bars = 20/50 μm, Black arrow: Alveolar expansion; Red arrow: Hemorrhage; Green arrow: Alveolar septum thickening and inflammatory cell infiltration). (F–G) Quantitative assessment of lung injury via histopathological scoring and wet/dry weight ratio. (H) Total cells count and protein concentration in BALF. (I) The mRNA expression of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ). (J–K) Oxidative stress <t>markers:</t> <t>T-AOC</t> and MDA. (L) Apoptosis-related gene expression ( caspase 9 , Bcl-2, BAX , <t>and</t> <t>Cyt-c</t> ). (M) Mitochondrial respiratory function measured by OCR. (N) Serum Cyt-c release. (O) TUNEL staining for apoptosis detection (scale bar = 20 μm). Data are presented as the mean ± SD; n = 6; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.
    Cyt C, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pmc12891905-90-24-33?v=Nanjing+Jiancheng+Bioengineering+Research+Institute+Co+Ltd
    Average 86 stars, based on 1 article reviews
    cyt c - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cyt c
    ACO2 overexpression protected against LIRI in mice. (A) Schematic of AAV9-mediated ACO2-OE in I/R mice. (B–C) ACO2 expression levels assessed by RT-qPCR and western blot. (D) Blood gas parameters (PaO 2 and PaCO 2 ) following I/R injury. (E) Representative H&E-stained lung sections (scale bars = 20/50 μm, Black arrow: Alveolar expansion; Red arrow: Hemorrhage; Green arrow: Alveolar septum thickening and inflammatory cell infiltration). (F–G) Quantitative assessment of lung injury via histopathological scoring and wet/dry weight ratio. (H) Total cells count and protein concentration in BALF. (I) The mRNA expression of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ). (J–K) Oxidative stress <t>markers:</t> <t>T-AOC</t> and MDA. (L) Apoptosis-related gene expression ( caspase 9 , Bcl-2, BAX , <t>and</t> <t>Cyt-c</t> ). (M) Mitochondrial respiratory function measured by OCR. (N) Serum Cyt-c release. (O) TUNEL staining for apoptosis detection (scale bar = 20 μm). Data are presented as the mean ± SD; n = 6; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.
    Cyt C, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pm41690088-71-31-41?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    cyt c - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Proteintech cyt c
    HIF disrupts mitochondrial homeostasis and decreases ATP production. (A–C) Representative immunofluorescence images show the subcellular localization and nuclear translocation <t>of</t> <t>AIF,</t> MIF, and Cytochrome c (Cyt c) in HCT15 and HCT116 cells following 24 h HIF treatment. (D, E) Quantification of intracellular reactive oxygen species (ROS) levels in HCT15 and HCT116 cells, respectively. (F, G) Quantification of mitochondrial ROS intensity using mitoSOX staining in HCT15 and HCT116 cells, respectively. (H, I) Oxygen consumption rate (OCR) fluorescence intensity in HCT15 and HCT116 cells, reflecting changes in mitochondrial respiration. (J, K) Relative intracellular ATP levels in HCT15 and HCT116 cells following HIF treatment. (L) Flow cytometric analysis of mitochondrial membrane potential (Δψm) in HCT15 and HCT116 cells after HIF treatment, assessed using JC‐1 staining. The red‐to‐green fluorescence intensity ratio was used to quantify alterations in membrane potential (right panels). ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Cyt C, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyt+c/pmc13045231-226-122-125?v=Proteintech
    Average 96 stars, based on 1 article reviews
    cyt c - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    PolG Mut mitochondria possess selective impairments to NAD-linked Respiration (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.

    Journal: iScience

    Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration

    doi: 10.1016/j.isci.2026.115184

    Figure Lengend Snippet: PolG Mut mitochondria possess selective impairments to NAD-linked Respiration (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.

    Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the Oroboros O2k system followed by Cyt C (10μM).

    Techniques: Isolation, Generated

    Respiratory capacity within the electron transport system remains intact in PolG Mut mice (A–H) Schematic representing the maximal respiratory capacity protocol. Real-time oxygen consumption ( J O 2 ) in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung following serial titration of the mitochondrial uncoupling agent, carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). (I) Maximal mitochondrial respiration achieved during FCCP titration. N = 5–6 per group, Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 depict significant post hoc LSD by two-way ANOVA; main effect PolG ( B–4H) or unpaired t test ( I). Substrates utilized are indicated as follows: pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), succinate (Succ; 5 mM) cytochrome c (Cyt C, 10 μM). Graphics were generated using BioRender.

    Journal: iScience

    Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration

    doi: 10.1016/j.isci.2026.115184

    Figure Lengend Snippet: Respiratory capacity within the electron transport system remains intact in PolG Mut mice (A–H) Schematic representing the maximal respiratory capacity protocol. Real-time oxygen consumption ( J O 2 ) in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung following serial titration of the mitochondrial uncoupling agent, carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). (I) Maximal mitochondrial respiration achieved during FCCP titration. N = 5–6 per group, Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 depict significant post hoc LSD by two-way ANOVA; main effect PolG ( B–4H) or unpaired t test ( I). Substrates utilized are indicated as follows: pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), succinate (Succ; 5 mM) cytochrome c (Cyt C, 10 μM). Graphics were generated using BioRender.

    Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the Oroboros O2k system followed by Cyt C (10μM).

    Techniques: Isolation, Titration, Generated

    Mitochondrial respiratory phenotypes are maintained in permeabilized tissue (A) Tissue slices were permeabilized in saponin before assessment of oxygen consumption ( J O 2 ). (B) Intact colon, (C) heart, and (D) liver J O 2 under multiple substrate conditions. (E) Ratio of complex I (CI) versus CII-supported respiration. (F) Dose-response to FCCP titration and (G) maximal respiratory capacity in intact bone marrow-derived mononuclear cells (BMMCs). (H) Mitochondrial J O 2 during OxPhos kinetics technique in permeabilized BMMCs. (I) Ratio of CI versus CII-supported respiration in permeabilized BMMCs. N = 5 per group. Data are presented as mean ± SEM, p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001,∗∗∗∗ p < 0.00001 depict significant multiple unpaired t tests ( A–6C and 6G), and unpaired t test ( D–6F and 6H). Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM), pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM) antimycin A (Ant A; 0.5 μM), and carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). Graphics were generated using BioRender.

    Journal: iScience

    Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration

    doi: 10.1016/j.isci.2026.115184

    Figure Lengend Snippet: Mitochondrial respiratory phenotypes are maintained in permeabilized tissue (A) Tissue slices were permeabilized in saponin before assessment of oxygen consumption ( J O 2 ). (B) Intact colon, (C) heart, and (D) liver J O 2 under multiple substrate conditions. (E) Ratio of complex I (CI) versus CII-supported respiration. (F) Dose-response to FCCP titration and (G) maximal respiratory capacity in intact bone marrow-derived mononuclear cells (BMMCs). (H) Mitochondrial J O 2 during OxPhos kinetics technique in permeabilized BMMCs. (I) Ratio of CI versus CII-supported respiration in permeabilized BMMCs. N = 5 per group. Data are presented as mean ± SEM, p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001,∗∗∗∗ p < 0.00001 depict significant multiple unpaired t tests ( A–6C and 6G), and unpaired t test ( D–6F and 6H). Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM), pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM) antimycin A (Ant A; 0.5 μM), and carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). Graphics were generated using BioRender.

    Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the Oroboros O2k system followed by Cyt C (10μM).

    Techniques: Titration, Derivative Assay, Generated

    ACO2 overexpression protected against LIRI in mice. (A) Schematic of AAV9-mediated ACO2-OE in I/R mice. (B–C) ACO2 expression levels assessed by RT-qPCR and western blot. (D) Blood gas parameters (PaO 2 and PaCO 2 ) following I/R injury. (E) Representative H&E-stained lung sections (scale bars = 20/50 μm, Black arrow: Alveolar expansion; Red arrow: Hemorrhage; Green arrow: Alveolar septum thickening and inflammatory cell infiltration). (F–G) Quantitative assessment of lung injury via histopathological scoring and wet/dry weight ratio. (H) Total cells count and protein concentration in BALF. (I) The mRNA expression of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ). (J–K) Oxidative stress markers: T-AOC and MDA. (L) Apoptosis-related gene expression ( caspase 9 , Bcl-2, BAX , and Cyt-c ). (M) Mitochondrial respiratory function measured by OCR. (N) Serum Cyt-c release. (O) TUNEL staining for apoptosis detection (scale bar = 20 μm). Data are presented as the mean ± SD; n = 6; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

    Journal: Redox Biology

    Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis

    doi: 10.1016/j.redox.2026.104016

    Figure Lengend Snippet: ACO2 overexpression protected against LIRI in mice. (A) Schematic of AAV9-mediated ACO2-OE in I/R mice. (B–C) ACO2 expression levels assessed by RT-qPCR and western blot. (D) Blood gas parameters (PaO 2 and PaCO 2 ) following I/R injury. (E) Representative H&E-stained lung sections (scale bars = 20/50 μm, Black arrow: Alveolar expansion; Red arrow: Hemorrhage; Green arrow: Alveolar septum thickening and inflammatory cell infiltration). (F–G) Quantitative assessment of lung injury via histopathological scoring and wet/dry weight ratio. (H) Total cells count and protein concentration in BALF. (I) The mRNA expression of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ). (J–K) Oxidative stress markers: T-AOC and MDA. (L) Apoptosis-related gene expression ( caspase 9 , Bcl-2, BAX , and Cyt-c ). (M) Mitochondrial respiratory function measured by OCR. (N) Serum Cyt-c release. (O) TUNEL staining for apoptosis detection (scale bar = 20 μm). Data are presented as the mean ± SD; n = 6; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

    Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and Cyt-c (Cat. No: H190-1-2) were quantified using commercial kits (Nanjing Jiancheng Bioengineering Institute) with a UV-VIS spectrophotometer.

    Techniques: Over Expression, Expressing, Quantitative RT-PCR, Western Blot, Staining, Protein Concentration, Gene Expression, TUNEL Assay

    ACO2-KO exacerbated mitochondrial damage and apoptosis in HUVECs. (A–B) Validation of ACO2-KO efficiency by RT-qPCR and western blot. (C) Representative TEM images showing mitochondrial ultrastructural changes. The red arrows indicate the disappearance of mitochondrial cristae. (D) Cellular ATP contents measured by enzymatic assay. (E) The mtDNA copy number assessed via quantification of mitochondrial genes (ND-1, COX I, and COX IV). (F) Mitochondrial superoxide production detected by MitoSOX Red staining (scale bar = 20 μm). (G) Mitochondrial respiratory function measured by OCR. (H–I) Metabolomic analysis of TCA cycle intermediates: itaconate and isocitrate. (J) The mRNA expression of apoptosis-related genes ( Bcl-2, BAX, and Caspase-9 ). (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, and ∗∗∗∗ P < 0.0001.

    Journal: Redox Biology

    Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis

    doi: 10.1016/j.redox.2026.104016

    Figure Lengend Snippet: ACO2-KO exacerbated mitochondrial damage and apoptosis in HUVECs. (A–B) Validation of ACO2-KO efficiency by RT-qPCR and western blot. (C) Representative TEM images showing mitochondrial ultrastructural changes. The red arrows indicate the disappearance of mitochondrial cristae. (D) Cellular ATP contents measured by enzymatic assay. (E) The mtDNA copy number assessed via quantification of mitochondrial genes (ND-1, COX I, and COX IV). (F) Mitochondrial superoxide production detected by MitoSOX Red staining (scale bar = 20 μm). (G) Mitochondrial respiratory function measured by OCR. (H–I) Metabolomic analysis of TCA cycle intermediates: itaconate and isocitrate. (J) The mRNA expression of apoptosis-related genes ( Bcl-2, BAX, and Caspase-9 ). (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, and ∗∗∗∗ P < 0.0001.

    Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and Cyt-c (Cat. No: H190-1-2) were quantified using commercial kits (Nanjing Jiancheng Bioengineering Institute) with a UV-VIS spectrophotometer.

    Techniques: Biomarker Discovery, Quantitative RT-PCR, Western Blot, Enzymatic Assay, Staining, Metabolomic, Expressing, TUNEL Assay

    4-OI rescued mitochondrial dysfunction after ACO2-KO in HUVECs. (A) Mitochondrial mass assessed by MitoTracker staining (scale bar = 20 μm). (B) Mitochondrial respiratory function measured by OCR. (C) Mitochondrial membrane potential evaluated using JC-1 staining (scale bar = 20 μm). (D) Activities of mitochondrial ETC complexes. (E) Protein contents of ETC complex subunits. (F–G) Metabolic ratios of NAD + /NADH and ATP/ADP. (H–I) The mRNA expression of apoptosis-related genes ( caspase-9 and BAX ). (J) Apoptosis-related protein contents (cleaved caspase-3, Bcl-2, and BAX) analyzed by western blot with semi-quantitative analysis. (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

    Journal: Redox Biology

    Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis

    doi: 10.1016/j.redox.2026.104016

    Figure Lengend Snippet: 4-OI rescued mitochondrial dysfunction after ACO2-KO in HUVECs. (A) Mitochondrial mass assessed by MitoTracker staining (scale bar = 20 μm). (B) Mitochondrial respiratory function measured by OCR. (C) Mitochondrial membrane potential evaluated using JC-1 staining (scale bar = 20 μm). (D) Activities of mitochondrial ETC complexes. (E) Protein contents of ETC complex subunits. (F–G) Metabolic ratios of NAD + /NADH and ATP/ADP. (H–I) The mRNA expression of apoptosis-related genes ( caspase-9 and BAX ). (J) Apoptosis-related protein contents (cleaved caspase-3, Bcl-2, and BAX) analyzed by western blot with semi-quantitative analysis. (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.

    Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and Cyt-c (Cat. No: H190-1-2) were quantified using commercial kits (Nanjing Jiancheng Bioengineering Institute) with a UV-VIS spectrophotometer.

    Techniques: Staining, Membrane, Expressing, Western Blot, TUNEL Assay

    HIF disrupts mitochondrial homeostasis and decreases ATP production. (A–C) Representative immunofluorescence images show the subcellular localization and nuclear translocation of AIF, MIF, and Cytochrome c (Cyt c) in HCT15 and HCT116 cells following 24 h HIF treatment. (D, E) Quantification of intracellular reactive oxygen species (ROS) levels in HCT15 and HCT116 cells, respectively. (F, G) Quantification of mitochondrial ROS intensity using mitoSOX staining in HCT15 and HCT116 cells, respectively. (H, I) Oxygen consumption rate (OCR) fluorescence intensity in HCT15 and HCT116 cells, reflecting changes in mitochondrial respiration. (J, K) Relative intracellular ATP levels in HCT15 and HCT116 cells following HIF treatment. (L) Flow cytometric analysis of mitochondrial membrane potential (Δψm) in HCT15 and HCT116 cells after HIF treatment, assessed using JC‐1 staining. The red‐to‐green fluorescence intensity ratio was used to quantify alterations in membrane potential (right panels). ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Advanced Science

    Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death

    doi: 10.1002/advs.202511406

    Figure Lengend Snippet: HIF disrupts mitochondrial homeostasis and decreases ATP production. (A–C) Representative immunofluorescence images show the subcellular localization and nuclear translocation of AIF, MIF, and Cytochrome c (Cyt c) in HCT15 and HCT116 cells following 24 h HIF treatment. (D, E) Quantification of intracellular reactive oxygen species (ROS) levels in HCT15 and HCT116 cells, respectively. (F, G) Quantification of mitochondrial ROS intensity using mitoSOX staining in HCT15 and HCT116 cells, respectively. (H, I) Oxygen consumption rate (OCR) fluorescence intensity in HCT15 and HCT116 cells, reflecting changes in mitochondrial respiration. (J, K) Relative intracellular ATP levels in HCT15 and HCT116 cells following HIF treatment. (L) Flow cytometric analysis of mitochondrial membrane potential (Δψm) in HCT15 and HCT116 cells after HIF treatment, assessed using JC‐1 staining. The red‐to‐green fluorescence intensity ratio was used to quantify alterations in membrane potential (right panels). ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: The membranes were then blocked with a 5% non‐fat milk TBST (TBS containing 0.1% Tween‐20) for 1 h at room temperature and incubated at 4°C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128‐1‐AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs‐1341R, Bioss), CDK2 (bs‐10726R, Bioss), CDK7 (bs‐0569R, Bioss), AKT (4691, CST), p‐AKT (4060, CST), ERK (9102, CST), p‐ERK (9101, CST), MEK (9126, CST), p‐MEK (9154, CST), ATR (13934, CST), p‐ATR (2853, CST), Chk1 (2360, CST), p‐Chk1 (2348, CST), RAD51 (14961‐1‐AP, Proteintech), ATM (27156‐1‐AP, Proteintech), p‐ATM (5883, CST), γ‐H2AX (9718, CST), AIF (5318, CST), MIF (75038, CST), Cyt c (10993‐1‐AP, Proteintech), Lamin B (66095‐1‐Ig, Proteintech), VDAC1 (81538‐1‐RR, Proteintech) and GAPDH (60004‐1‐Ig, Proteintech).

    Techniques: Immunofluorescence, Translocation Assay, Staining, Fluorescence, Membrane

    HIF suppresses CRC tumor growth in vivo. (A) Tumor growth in mouse models bearing HCT116 cells treated with HIF, 5‐FU, or the combination. (B) Final tumor weights were measured at the end of treatment across treatment groups. (C) Representative images of excised tumors from each group. (D) Body weight monitoring throughout the treatment period. (E, F) H&E and IHC analysis of tumor tissues for Ki67, Cyt c, c‐Caspase‐3, and c‐PARP, with corresponding quantification. (G) H&E and IHC staining of kidney and liver tissues to evaluate potential organ toxicity. (H–J) Immunofluorescence analysis of γ‐H2AX, AIF, and MIF localization in tumor tissues. Nuclei are stained with DAPI (blue), and target proteins appear in green. (K) Schematic representation illustrating the proposed mechanism by which HIF‐induced DNA damage leads to mitochondrial apoptosis and parthanatos‐mediated colorectal tumor cell death. ** p < 0.01, **** p < 0.0001.

    Journal: Advanced Science

    Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death

    doi: 10.1002/advs.202511406

    Figure Lengend Snippet: HIF suppresses CRC tumor growth in vivo. (A) Tumor growth in mouse models bearing HCT116 cells treated with HIF, 5‐FU, or the combination. (B) Final tumor weights were measured at the end of treatment across treatment groups. (C) Representative images of excised tumors from each group. (D) Body weight monitoring throughout the treatment period. (E, F) H&E and IHC analysis of tumor tissues for Ki67, Cyt c, c‐Caspase‐3, and c‐PARP, with corresponding quantification. (G) H&E and IHC staining of kidney and liver tissues to evaluate potential organ toxicity. (H–J) Immunofluorescence analysis of γ‐H2AX, AIF, and MIF localization in tumor tissues. Nuclei are stained with DAPI (blue), and target proteins appear in green. (K) Schematic representation illustrating the proposed mechanism by which HIF‐induced DNA damage leads to mitochondrial apoptosis and parthanatos‐mediated colorectal tumor cell death. ** p < 0.01, **** p < 0.0001.

    Article Snippet: The membranes were then blocked with a 5% non‐fat milk TBST (TBS containing 0.1% Tween‐20) for 1 h at room temperature and incubated at 4°C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128‐1‐AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs‐1341R, Bioss), CDK2 (bs‐10726R, Bioss), CDK7 (bs‐0569R, Bioss), AKT (4691, CST), p‐AKT (4060, CST), ERK (9102, CST), p‐ERK (9101, CST), MEK (9126, CST), p‐MEK (9154, CST), ATR (13934, CST), p‐ATR (2853, CST), Chk1 (2360, CST), p‐Chk1 (2348, CST), RAD51 (14961‐1‐AP, Proteintech), ATM (27156‐1‐AP, Proteintech), p‐ATM (5883, CST), γ‐H2AX (9718, CST), AIF (5318, CST), MIF (75038, CST), Cyt c (10993‐1‐AP, Proteintech), Lamin B (66095‐1‐Ig, Proteintech), VDAC1 (81538‐1‐RR, Proteintech) and GAPDH (60004‐1‐Ig, Proteintech).

    Techniques: In Vivo, Immunohistochemistry, Immunofluorescence, Staining